Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain-Reference-Cited by-同舟云学术

Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain

Published:2015-05 Issue:22 Volume:290 Page:13875-13887
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Zhao Peishen,Lieu TinaMarie,Barlow Nicholas,Sostegni Silvia,Haerteis Silke,Korbmacher Christoph,Liedtke Wolfgang,Jimenez-Vargas Nestor N.,Vanner Stephen J.,Bunnett Nigel W.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference64 articles.

1. Protease-activated receptors: contribution to physiology and disease;Ossovskaya;Physiol. Rev,2004

2. Protease-activated receptors as drug targets in inflammation and pain;Vergnolle;Pharmacol. Ther,2009

3. Proteinase-activated receptors;Macfarlane;Pharmacol. Rev,2001

4. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2;Nystedt;Eur. J. Biochem,1995

5. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway;Vergnolle;Nat. Med,2001

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2;Gut Microbes;2024-08-22

2. Extracellular Vesicle-Associated Neutrophil Elastase Activates Hepatic Stellate Cells and Promotes Liver Fibrogenesis via ERK1/2 Pathway;2024-08-21

3. Robustaflavone as a novel scaffold for inhibitors of native and auto-proteolysed human neutrophil elastase;SAR and QSAR in Environmental Research;2024-08-02

4. Immunomodulation and fibroblast dynamics driving nociceptive joint pain within inflammatory synovium: Unravelling mechanisms for therapeutic advancements in osteoarthritis;Osteoarthritis and Cartilage;2024-07

5. Targeting TRPV4 Channels for Cancer Pain Relief;Cancers;2024-04-27